Join to access to all OVN content. Join for Free
From Clinical to Medical Device MSL and Beyond
Medical Science Liaison MSL roles medical device industry transitioning MSL International MSL Day

From Clinical to Medical Device MSL and Beyond


Share This Article


Summary

In this episode, Maria Abunto joins Tom Caravela to discuss her journey from clinical practice to becoming a successful Medical Science Liaison (MSL) in the medical device industry. Maria shares insights on why clinicians are well-suited for MSL roles and the importance of mentors and career coaches. The conversation delves into transitioning within MSL roles, adapting to the pandemic's impact, and the evolving future of MSL work. Maria offers valuable advice for aspiring MSLs, touching on changes in metrics and KPIs. The episode concludes with a celebration of International MSL Day and a call for listener feedback.

Check out my latest podcast with Maria Abunto, Medical Science Liaison at Exact Sciences who discusses her path from clinician to a Medical Device MSL and beyond.

Maria shares….

 What is a Medical Device MSL
 How are Med Device MSLs different than therapeutic MSLs
 Why is it so important to be organized for territory excellence
 Advice for MSLs now and for the future

Click for Source
Medical Science Liaison, MSL roles, medical device industry, transitioning MSL, International MSL Day

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN